NDC 49281-590-10

MenQuadfi 10 ug/.5mL

NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN · INJECTION, SOLUTION

No Recall History

MenQuadfi is a injection, solution containing neisseria meningitidis group a capsular polysaccharide tetanus toxoid conjugate antigen, neisseria meningitidis group c capsular polysaccharide tetanus toxoid conjugate antigen, neisseria meningitidis group y capsular polysaccharide tetanus toxoid conjugate antigen, and neisseria meningitidis group w-135 capsular polysaccharide tetanus toxoid conjugate antigen at a strength of 10 ug/.5mL. Manufactured by Sanofi Vaccines US Inc..

Key Facts

Brand Name: MenQuadfi
Generic Name: NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN
NDC Code (Package): 49281-590-10
NDC Code (Product): 49281-590
Manufacturer: Sanofi Vaccines US Inc.
Strength: 10 ug/.5mL
Dosage Form: INJECTION, SOLUTION
Route: INTRAMUSCULAR
Marketing Status
Application #: BLA125701
Marketing Start: 04/23/2020

Recall History

No Recall History

View Full Drug Page

MenQuadfi — All Packages

Not medical advice. This information is for reference only. Always consult your doctor or pharmacist.